Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Novel regenerative drug, SPG302 promotes functional recovery of ...
Novel Regenerative Drug, SPG302 Promotes Functional Recovery of ...
SPG302 Reverses Synaptic and Cognitive Deficits Without Altering ...
Spinogenix's Daily Pill SPG302 Receives FDA IND Nod for ALS Treatment
Spinogenix’s world first drug SPG302 could reverse the decline in ...
Spinogenix 宣布 SPG302 在青光眼模型中具神经保护作用的临床前研究 - 知乎
Spinogenix Reports Positive Phase 2a Results for ALS Drug Candidate SPG302
Clinical trial of oral ALS therapy SPG302 is enrolling in Australia ...
FDA Clears Phase 1/2 Clinical Trial for Spinogenix’s ALS Treatment SPG302
Spinogenix Granted FDA Orphan Drug Designation for SPG302
Spinogenix's SPG302 Oral Therapy for ALS Named Orphan Drug by FDA
Spinogenix, SPG302 임상 1/2상 시험 미국에서 곧 시작 - 레어노트
Spinogenix Announces FDA-Authorized Expanded Access Program for SPG302 ...
FDA Authorizes Expanded Access Program for ALS Treatment SPG302
FDA clears expanded access program for SPG302 in ALS patients ...
(PDF) SPG302 Reverses Synaptic and Cognitive Deficits Without Altering ...
SPG302 | Drug Information, Uses, Side Effects, Chemistry ...
FDA OKs Phase 1/2 clinical trial of small molecule SPG302 in ALS
FDA clears expanded access program for SPG302 in ALS patients
FDA Authorizes Expanded Access Program for ALS Treatment SPG302 ...
Start der Phase-II-Studie für neues ALS-Medikament SPG302
Novel motor neurone disease, MND, drug SPG302 to be trialled in ...
SPG302 para esclerosis lateral amiotrófica recibe designación de ...
Findings From First Cohort of SPG302 in Phase 2 Alzheimer Disease Trial ...
Can SPG302 Rebuild My Brain? | Schizophrenia in 2025 - YouTube
Early Clinical Development of Synapse-Focused Agent SPG302 for ...
Experimental oral therapy SPG302 may slow ALS progression
SPG-302
Spinogenix's SPG302: A Hopeful Treatment Breakthrough for ALS Patients ...
Science - Spinogenix
Spinogenix advances SPG-302 into clinic in Australia for ALS | BioWorld
First dose of spg-302 - Medications - Schizophrenia.com
FDA grants IND clearance for Spinogenix's ALS treatment trial
FDA Clears Phase 1/2 Clinical Trial for Spinogenix’s ALS Treatment ...
Spinogenix’s ALS Breakthrough: A Los Angeles-Based Biotech’s Bold Leap ...
Spinogenix's SPG302, the First Synaptic Regenerative Therapy to Treat ...
Spinogenix is pioneering therapeutics that restore synapses to improve ...
Restoring Brain Synapses Pipeline - Spinogenix
Spinogenix Launches Phase II Trial for Synaptic Regenerative Therapy in ...
新型再生药物SPG302促进颈脊髓损伤后膈肌活动功能恢复,The Journal of Physiology - X-MOL
Spinogenix Secures INN Approval for Tazbentetol — A New Era in Synaptic ...
Press Releases - Spinogenix
Revolutionary ALS Pill, SPG302, Enters Phase 2: A New Dawn in ...
让罕见被看见，“解冻”渐冻症的新疗法
$1M awarded to advance ALS therapy SPG302's clinical testing | ALS News ...
FDA Clears Neuralace Medical’s Noninvasive Axon Therapy for Painful ...
Spinogenix is developing a new class of regenerative therapeutics
Preliminary Phase 2 Data Support Therapeutic Development of Synaptic ...
SPG302: A Synaptic Regenerative Treatment Option for Schizophrenia
SPG 302 Cognitive Vitality For Researchers | PDF | Synapse | Alzheimer ...
Spinogenix to conduct world-first clinical trial in Australia ...
Media - Spinogenix
Phase 2 Trial Open Enrollment for SPG302, First Synaptic Regenerative ...
Reset the Clock on Schizophrenia: SPG302, A Regenerative Treatment
Companies To Watch Spinogenix
2-(2-(2-(2-(4-(苯并[D]噻唑-2-基)苯氧基)乙氧基)乙氧基)乙氧基)乙醇 CAS#: 2274723-90-7
SPG302可减缓渐冻症患者的疾病进展，其2a期临床试验初步结果积极-上市-医保-临床适应症-香港济民药业
EAP Program Authorized for ALS Agent SPG302, PTC518 Meets Primary End ...
有没有朋友介绍一下SPG302这款药物？ - 知乎
Spinogenix’s Alzheimer’s drug touts disease-modifying potential in ...
SPG
EPOS/Sennheiser SPG 302 Microphone - DiscoAzul.com
Illustration showing the assumed mechanism underlying how a block of ...
Spg-302 vs Evenamide - Medications - Schizophrenia.com
SPG 302 Midterm Exam.docx - Diana Tokar Time completed 1hr 46 min SPG ...
SPG stimulation in the RB-treated cortex. A, Brain surface images in a ...
SPG Presentation 1-2015 (1) | PPT
8" X 9" MONUMENT BODY & COVER | Standard Products Group
AI for ALS - SPG-302 - YouTube
